The present invention includes an apparatus for transdermal treatments comprising: an openable enclosure for a subject in communication with three or more sources of treatment modalities selected from: a source of ozone; a source of steam, a source of CO.sub.2/Carbonic Acid; a source of Far Infrared; and a source of pulsed electromagnetic fields (PEMF), wherein each of the three or more sources is in communication with an interior of the openable enclosure to treat the subject transdermally.

A system (5) for generating a gaseous mixture for an enclosure (7) for treatment of a wound (3), comprising a generator (11) for generating the gaseous mixture and for delivering said gaseous mixture to the treatment enclosure (7) at a defined flow rate, the generator (11) of the gaseous mixture being designed to vary a molar fraction of dioxygen of said delivered gaseous mixture and to vary a molar fraction of water vapour of said delivered gaseous mixture, a control unit (39) which serves for controlling the delivered gaseous mixture and is provided with a processor (41) for receiving information relating to a pressure (P) inside the treatment enclosure (7) and/or designed to determine a flow rate of said gaseous mixture to be delivered in the treatment enclosure (7) in order to obtain an internal target pressure, the target pressure being defined by a time variation function of the pressure between a minimum pressure, corresponding to an ambient pressure outside the treatment enclosure (7), and a maximum pressure.

A system (5) for generating a gaseous mixture for an enclosure (7) for treatment of a wound (3), comprising a generator (11) for generating the gaseous mixture and for delivering said gaseous mixture to the treatment enclosure (7) at a defined flow rate, the generator (11) of the gaseous mixture being designed to vary a molar fraction of dioxygen of said delivered gaseous mixture and to vary a molar fraction of water vapour of said delivered gaseous mixture, a control unit (39) which serves for controlling the delivered gaseous mixture and is provided with a processor (41) for receiving information relating to a pressure (P) inside the treatment enclosure (7) and/or designed to determine a flow rate of said gaseous mixture to be delivered in the treatment enclosure (7) in order to obtain an internal target pressure, the target pressure being defined by a time variation function of the pressure between a minimum pressure, corresponding to an ambient pressure outside the treatment enclosure (7), and a maximum pressure.

An eye mask-type hydrogen supply device that is freely portable when carried by a user and with which it is possible to supply hydrogen to the areas around both eyes and the eyeballs while warming the eyelids, wherein the eye mask-type hydrogen supply device can be used continuously by replacing a hydrogen gas supply pack.

An eye mask-type hydrogen supply device that is freely portable when carried by a user and with which it is possible to supply hydrogen to the areas around both eyes and the eyeballs while warming the eyelids, wherein the eye mask-type hydrogen supply device can be used continuously by replacing a hydrogen gas supply pack.

A hydrogen-delivering system for topical application of molecular hydrogen is provided. The system includes a housing that comprises at least one dry chemical and a liquid composition sealed therein, and that is configured to be attached to a target area of a subject's skin. The dry chemical and the aqueous composition are separated within the housing until the system is activated and the dry chemical and the aqueous composition are mixed to generate molecular hydrogen. The molecular hydrogen passes through a skin-facing surface of the housing, which is permeable to hydrogen and not permeable to the dry chemical and the aqueous composition, and is delivered to the subject's body.

The present invention provides an apparatus for producing medical foam for wound care or hair stimulation. The apparatus includes a foam generation unit having a fluid reservoir, a fluid delivery line and a foam generation tip. The apparatus also includes a compressed gas unit having at least one container of compressed gas, a source of electric power, and a gas regulator valve. A supply of wound care or hair stimulating solution is communicably connected to the foam generation tip such that when the apparatus is operated medical foam is produced by the foam generator tip.

The present application provides a radiation damage protecting agent comprising hydrogen gas as an active ingredient at a concentration of 18.5% by volume or less, for treating or alleviating, in a hyperbaric capsule under a pressure higher than standard atmospheric pressure, radiation damage in a human patient who has been exposed to radiation or who has received or receives radiotherapy, and a hyperbaric capsule for administering a hydrogen gas-containing therapeutic agent such as the radiation damage protecting agent to a patient including a human.

The present application provides a radiation damage protecting agent comprising hydrogen gas as an active ingredient at a concentration of 18.5% by volume or less, for treating or alleviating, in a hyperbaric capsule under a pressure higher than standard atmospheric pressure, radiation damage in a human patient who has been exposed to radiation or who has received or receives radiotherapy, and a hyperbaric capsule for administering a hydrogen gas-containing therapeutic agent such as the radiation damage protecting agent to a patient including a human.

A therapeutic device for treating conditions of a user's nasal cavities, sinuses, and/or ear canals includes a housing which the user may hold to apply the therapeutic device to the user, the housing including an inlet that allows air to enter the therapeutic device. An acoustic vibrator located within the housing provides an acoustic vibration to the user, and a power supply located within the housing provides power to the acoustic vibrator. A mask is connected to the housing and includes a nasal interface that is appliable around the nose of the user. A valve of the mask opens to allow the user to breathe through the inlet and closes to prevent the user from exhaling through the inlet. The mask further includes a diaphragm and a nasal cavity in which a user's nostrils are located when the nasal interface is applied to the user.